TELK

4:31 pm Telik and MabVax Therapeutics enter into a definitive merger agreement; MabVax will merge with a wholly-owned subsidiary of Telik in an all-stock transaction

moreView todays social media effects on TELKView the latest stocks trending across Twitter. Click to view dashboardSee who Telik is hiring next, click here to view […]

MabVax Therapeutics And Telik Sign Definitive Merger Agreement

[PR Newswire] – SAN DIEGO, May 12, 2014 /PRNewswire/ — MabVax Therapeutics, Inc., a privately held cancer immunotherapy company and Telik, Inc. (TELK), aclinical stage oncology drug development company have entered into a definitive merger agreement. Up moreView todays social media effects on TELKView the latest stocks trending across Twitter. Click to view dashboardSee who Telik is hiring next, click […]

Telik and MabVax Therapeutics Announce Definitive Merger Agreement

[PR Newswire] – PALO ALTO, Calif., May 12, 2014 /PRNewswire/ — Telik, Inc. (TELK), a clinical stage oncology drug development company, and MabVax Therapeutics, Inc., a privately held cancer immunotherapy company, have entered into a definitive merger ag moreView todays social media effects on TELKView the latest stocks trending across Twitter. Click to view dashboardSee who Telik is hiring next, […]

Telik trading halted, pending news

moreView todays social media effects on TELKView the latest stocks trending across Twitter. Click to view dashboardSee who Telik is hiring next, click here to view […]

Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Financial Guidance

[PR Newswire] – PALO ALTO, Calif., March 15, 2013 /PRNewswire/ — Telik, Inc. (Nasdaq: TELK) reported a net loss of $1.8 million, or $0.66 per share, for the three months ended December 31, 2012, compared with a net loss … moreView todays social media effects on TELKView the latest stocks trending across Twitter. Click to view dashboardSee who Telik is […]